72
Views
17
CrossRef citations to date
0
Altmetric
Research Article

Evaluation of serum cystatin C and chromogranin A as markers of nephropathy in patients with Type 2 diabetes mellitus

, &
Pages 483-489 | Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Michele Mussap & Mario Plebani. (2004) Biochemistry and Clinical Role of Human Cystatin C. Critical Reviews in Clinical Laboratory Sciences 41:5-6, pages 467-550.
Read now

Articles from other publishers (15)

Xueling Liao, Yan Zhu & Chao Xue. (2022) Diagnostic value of serum cystatin C for diabetic nephropathy: a meta-analysis. BMC Endocrine Disorders 22:1.
Crossref
Hui Yu, Hongping Wang, Xue Su, Aili Cao, Xingmei Yao, Yunman Wang, Bingbing Zhu, Hao Wang & Ji Fang. (2022) Serum chromogranin A correlated with albuminuria in diabetic patients and is associated with early diabetic nephropathy. BMC Nephrology 23:1.
Crossref
Xiaobao Wei, Runyue Hu, Xiaoli Zhou, Lihua Ni, Dongqing Zha, Huiling Feng, Haibo Xu & Xiaoyan Wu. (2022) Alterations of Renal Function in Patients with Diabetic Kidney Disease: A BOLD and DTI Study. Computational Intelligence and Neuroscience 2022, pages 1-11.
Crossref
Bhuneshwar Yadav, Shashidhar K.N, Raveesha A & Muninarayana C.. (2021) Assessment of Cystatin C and Microalbumin as Biomarkers for Nephropathy in Patients with Type 2 Diabetes Mellitus. Journal of Evolution of Medical and Dental Sciences 10:25, pages 1866-1870.
Crossref
Marlene Tapper, Donovan A. McGrowder, Lowell Dilworth & Adedamola Soyibo. (2021) Cystatin C, Vitamin D and Thyroid Function Test Profile in Chronic Kidney Disease Patients. Diseases 9:1, pages 5.
Crossref
Kasper Broedbaek & Linda Hilsted. (2016) Chromogranin A as biomarker in diabetes. Biomarkers in Medicine 10:11, pages 1181-1189.
Crossref
Alaaeldin M. Bashier, Ayman Aly Seddik Fadlallah, Nada Alhashemi, Puja Murli Thadani, Elamin Abdelgadir & Fauzia Rashid. (2015) Cystatin C and Its Role in Patients with Type 1 and Type 2 Diabetes Mellitus. Advances in Endocrinology 2015, pages 1-8.
Crossref
L. Ghys, D. Paepe, P. Smets, H. Lefebvre, J. Delanghe & S. Daminet. (2014) Cystatin C: A New Renal Marker and Its Potential Use in Small Animal Medicine. Journal of Veterinary Internal Medicine 28:4, pages 1152-1164.
Crossref
Laura W. Harris, Paul C. Guest, Matthew T. Wayland, Yagnesh Umrania, Divya Krishnamurthy, Hassan Rahmoune & Sabine Bahn. (2013) Schizophrenia: Metabolic aspects of aetiology, diagnosis and future treatment strategies. Psychoneuroendocrinology 38:6, pages 752-766.
Crossref
Young Jae JungHyang Ran LeeOh Jung Kwon. (2012) Comparison of serum cystatin C and creatinine as a marker for early detection of decreasing glomerular filtration rate in renal transplants. Journal of the Korean Surgical Society 83:2, pages 69.
Crossref
Tiancheng Wang, Guang Jia, Ji Zhang, Yanhui Ma, Weiyue Feng, Lanzheng Liu, Ning Zhang, Lei Yan, Xiang Wang, Xueyan Zhang, Zihong Liu, Xianmei Du & Sen Zhen. (2010) Renal impairment caused by chronic occupational chromate exposure. International Archives of Occupational and Environmental Health 84:4, pages 393-401.
Crossref
Paul C. Guest, Daniel Martins-de-Souza, Natacha Vanattou-Saifoudine, Laura W. Harris & Sabine Bahn. 2011. Biomarkers of Neurological and Psychiatric Disease. Biomarkers of Neurological and Psychiatric Disease 145 168 .
Wen-Fang Huang, Bo Huang, Yong-Chang Yang, Dai-Wen Xiao, Hua Liu, Wei Jiang & Qi Hu. (2009) Application of A Serum Protein Fingerprinting Model in The Diagnosis of Type 2 Diabetic Nephropathy. Laboratory Medicine 40:6, pages 345-348.
Crossref
Y-H. Yang, S. Zhang, J-F. Cui, B. Lu, X-H. Dong, X-Y. Song, Y-K. Liu, X-X. Zhu & R-M. Hu. (2007) Original Article: Complications. Diagnostic potential of serum protein pattern in Type 2 diabetic nephropathy. Diabetic Medicine 24:12, pages 1386-1392.
Crossref
Olusegun A Mojiminiyi & Nabila Abdella. (2003) Evaluation of cystatin C and β-2 microglobulin as markers of renal function in patients with type 2 diabetes mellitus. Journal of Diabetes and its Complications 17:3, pages 160-168.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.